Dermata Therapeutics Inc (DRMA)

[The Night Stalker]

·

To elect three director nominees to serve as directors until the 2026 annual meeting of stockholders;

·

To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the year ending December 31, 2023;

·

To approve an amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of the shares of common stock authorized for issuance thereunder by 513,150 shares to 629,069 shares; and

·

To consider any other matters that may properly come before the Annual Meeting.



Only stockholders of record at the close of business on June 5, 2023 are entitled to receive notice of and to vote at the Annual Meeting or any postponement or adjournment thereof.

[The Night Stalker]

We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."

[The Night Stalker]

https://stockcharts.com/h-sc/ui?s=drma&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

[The Night Stalker]

next push breaks 2.09

[The Night Stalker]

next push breaks 2.09

[The Night Stalker]

https://stockcharts.com/h-sc/ui?s=drma&p=D&yr=1&mn=1&dy=0&id=p24986097784&listNum=23&a=1113701411

[The Night Stalker]

https://stockcharts.com/h-sc/ui?s=drma&p=D&yr=1&mn=1&dy=0&id=p24986097784&listNum=23&a=1113701411

[The Night Stalker]

drop the news

[The Night Stalker]

need a pump

[The Night Stalker]

the science here beats current acne twice daily applications, once weekly application is unheard of

doubled up at 1.57. so im averaged down for this

from a faggot chart perspective it may be ready if news is good

https://finance.yahoo.com/chart/DRMA?technical=all&ncid=dcm_306158732_490172245_127172993#eyJpbnRlcnZhbCI6ImRheSIsInBlcmlvZGljaXR5IjoxLCJ0aW1lVW5pdCI6bnVsbCwiY2FuZGxlV2lkdGgiOjgsImZsaXBwZWQiOmZhbHNlLCJ2b2x1bWVVbmRlcmxheSI6dHJ1ZSwiYWRqIjp0cnVlLCJjcm9zc2hhaXIiOnRydWUsImNoYXJ0VHlwZSI6ImxpbmUiLCJleHRlbmRlZCI6ZmFsc2UsIm1hcmtldFNlc3Npb25zIjp7fSwiYWdncmVnYXRpb25UeXBlIjoib2hsYyIsImNoYXJ0U2NhbGUiOiJsaW5lYXIiLCJzdHVkaWVzIjp7IuKAjHZvbCB1bmRy4oCMIjp7InR5cGUiOiJ2b2wgdW5kciIsImlucHV0cyI6eyJpZCI6IuKAjHZvbCB1bmRy4oCMIiwiZGlzcGxheSI6IuKAjHZvbCB1bmRy4oCMIn0sIm91dHB1dHMiOnsiVXAgVm9sdW1lIjoiIzAwYjA2MSIsIkRvd24gVm9sdW1lIjoiI2ZmMzMzYSJ9LCJwYW5lbCI6ImNoYXJ0IiwicGFyYW1ldGVycyI6eyJ3aWR0aEZhY3RvciI6MC40NSwiY2hhcnROYW1lIjoiY2hhcnQifX19LCJwYW5lbHMiOnsiY2hhcnQiOnsicGVyY2VudCI6MSwiZGlzcGxheSI6IkRSTUEiLCJjaGFydE5hbWUiOiJjaGFydCIsImluZGV4IjowLCJ5QXhpcyI6eyJuYW1lIjoiY2hhcnQiLCJwb3NpdGlvbiI6bnVsbH0sInlheGlzTEhTIjpbXSwieWF4aXNSSFMiOlsiY2hhcnQiLCLigIx2b2wgdW5kcuKAjCJdfX0sInNldFNwYW4iOnt9LCJsaW5lV2lkdGgiOjIsInN0cmlwZWRCYWNrZ3JvdW5kIjp0cnVlLCJldmVudHMiOnRydWUsImNvbG9yIjoiIzAwODFmMiIsInN0cmlwZWRCYWNrZ3JvdWQiOnRydWUsImV2ZW50TWFwIjp7ImNvcnBvcmF0ZSI6eyJkaXZzIjp0cnVlLCJzcGxpdHMiOnRydWV9LCJzaWdEZXYiOnt9fSwic3ltYm9scyI6W3sic3ltYm9sIjoiRFJNQSIsInN5bWJvbE9iamVjdCI6eyJzeW1ib2wiOiJEUk1BIiwicXVvdGVUeXBlIjoiRVFVSVRZIiwiZXhjaGFuZ2VUaW1lWm9uZSI6IkFtZXJpY2EvTmV3X1lvcmsifSwicGVyaW9kaWNpdHkiOjEsImludGVydmFsIjoiZGF5IiwidGltZVVuaXQiOm51bGwsInNldFNwYW4iOnt9fV19

[The Night Stalker]

its a process it doesn't happen over night - Jeffery Dahmer

[The Night Stalker]

next 2 weeks if all goes well with FDA we will get our push

[The Night Stalker]

We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."

[The Night Stalker]

We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."

[The Night Stalker]

can break 2.09 this week

[The Night Stalker]

can break 2.09 this week

[The Night Stalker]

starting

[The Night Stalker]

starting

[The Night Stalker]

https://stockcharts.com/freecharts/gallery.html?drma

[The Night Stalker]

We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."

[The Night Stalker]

https://www.barchart.com/stocks/quotes/DRMA/technical-chart?plot=BAR&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=DRMA&grid=1&height=500&studyheight=100

[The Night Stalker]

https://www.barchart.com/stocks/quotes/DRMA/technical-chart?plot=BAR&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=DRMA&grid=1&height=500&studyheight=100

[The Night Stalker]

still here, market has twice daily creams for acne, but this is the first once weekly application, hit 2.08 other day, the number ratio has a solid effectiveness rate here. doubled up at 1.57. with FDA event in coming weeks

[The Night Stalker]

nasTy

[The Night Stalker]

nasTy

[The Night Stalker]

once weekly acne application current market has twice daily cream 10 billion market at 5.2m marketcap

[The Night Stalker]

we see higher volume days ahead-

[The Night Stalker]

- DMT310 once-weekly topical treatment demonstrated statistically significant improvements at all time points in the three primary endpoints, inflammatory lesion count, noninflammatory lesion count, and Investigator Global Assessment (IGA) -

- DMT310 significantly reduced inflammatory lesions by 45% after only 4 treatments in patients with moderate-to-severe acne -

- FDA responses to DMT310 End of Phase 2 meeting package expected by the end this month -

SAN DIEGO, CA / ACCESSWIRE / June 8, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("De

[The Night Stalker]

- DMT310 once-weekly topical treatment demonstrated statistically significant improvements at all time points in the three primary endpoints, inflammatory lesion count, noninflammatory lesion count, and Investigator Global Assessment (IGA) -

- DMT310 significantly reduced inflammatory lesions by 45% after only 4 treatments in patients with moderate-to-severe acne -

- FDA responses to DMT310 End of Phase 2 meeting package expected by the end this month -

SAN DIEGO, CA / ACCESSWIRE / June 8, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("De

[The Night Stalker]

want to see higher volume days and the milestone will see big push

[The Night Stalker]

going higher

[The Night Stalker]

going higher

[The Night Stalker]

known for big swings, another big swing in store here in coming weeks with this micro floater,

[The Night Stalker]

lets see 2 and build it up as we await for milestone

[The Night Stalker]

- insert big blocks-

[The Night Stalker]

nice eod action, known for large swings, with the milestone event in june,, will see large pops ahead ,,,,,,,

[The Night Stalker]

strong, reversal starting

[The Night Stalker]

nice eod hits, we see volume it goes as we await for milestone event

[The Night Stalker]

https://www.barchart.com/stocks/quotes/DRMA/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=DRMA&grid=1&height=500&studyheight=100

[The Night Stalker]

https://www.barchart.com/stocks/quotes/DRMA/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=DRMA&grid=1&height=500&studyheight=100

[The Night Stalker]

https://www.barchart.com/stocks/quotes/DRMA/technical-chart?plot=BAR&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=0&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=DRMA&grid=1&height=500&studyheight=100

[The Night Stalker]

not getting that fire power volume, slow reversal

[TommyBoyTrader9460]

$DBMM

$DBMM Watching close for penny break..could be a mover this week..
TommyBoyTrader Telegram Room..charts and conversation..its free and all are welcome!https://t.co/hgN1IiEdJp pic.twitter.com/Z0Yu6wo7Jj

— Tommy Boy Trader (@QuabbinR) June 4, 2023

[The Night Stalker]

had to average down here. offerings bs is how it works with bigboard biotechs. they all do it, yet run big on events, pending big event in june, hold for events with 4m OS,, hence big swings before

best to buy them in wedge chart an wait for events

[TheFinalCD]

wtf

[The Night Stalker]

ran t0 1.93 like butter, was nice comeback friday with nice action, event in june

[The Night Stalker]

was crucial for a comeback on friday

[The Night Stalker]

with this buying pressure we saw friday if it contiues can see 2

[The Night Stalker]

going over my 40 biotech watchlist, the offerings are everyday practice on Nasdaq imo our milestone event will be worth the wait

[The Night Stalker]

got loaded today, we see some action next week it goes, been a bumpy sick ride, usually i sell at loss, with big board bio techs, hold for events